• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Breast cancer: VuCOMP wins expanded PMA for digital mammogram analysis

Breast cancer: VuCOMP wins expanded PMA for digital mammogram analysis

October 18, 2012 By MassDevice staff

breast cancer digital mammogram

Medical imaging analysis devices maker VuCOMP touted FDA premarket approval for its new M-Vu system for helping radiologists detect breast cancer earlier.

The Version 2 M-Vu system’s new indication allows the company to market its devices as an computer-aided detection adjunct to digital mammography.

The next-generation system is approved to work with twice as many vendors as any other mammography CAD product, including those by Philips (NYSE:PHG), Siemens (NYSE:SI), Hologic (NSDQ:HOLX) and others, according to a press release.

That means clinics that host a variety of systems from a variety of vendors can rely on a single CAD solution, VuCOMP noted.

The system is also the only FDA-approved mammography CAD to have met the FDA’s requirements that the system demonstrate, through comprehensive reader studies, that radiologists are more effective in detecting breast cancer when using CAD, according to a press release.

The Version 2 M-Vu also aims to cut back on noise and false-positives in analyzing mammogram images.

"We are seeing far fewer marks with VuCOMP’s CAD than with our current CAD system, and the marks make more sense to me," Boston Breast Diagnostic Center medical director Dr. Elsie Levin said in prepared remarks. "When there are many marks across 4 images, as with some other CAD systems, your mind automatically tends to dismiss them. Obviously, we do look at each mark, but it can be frustrating because there are just so many that don’t show any suspicious signs. With VuCOMP’s CAD, because we’re seeing far fewer marks, I have more confidence that these are significant findings. This allows me to spend my time more efficiently."

VuCOMP in January won FDA premarket approval for the original system.

Filed Under: Food & Drug Administration (FDA), Mammography, News Well, Pre-Market Approval (PMA) Tagged With: Breast Cancer, VuComp Inc.

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy